Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Hovione Expands Particle Design Solutions | Contract Pharma

What are you searching for?

Sign in
Breaking News

Hovione Expands Particle Design Solutions

Services aim to solve drug delivery challenges

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Hovione has expanded its solutions to solve issues of poor bioavailability, patient acceptability and to enable optimal delivery for non-oral routes of administration. The company’s portfolio of services now includes crystal design, particle size reduction to the micro or nano-scale and amorphous solid dispersions. These services are offered from bench to commercial scale and are supplemented with formulation development and clinical manufacture to Phase II.
 
“We are very pleased to offer our customers these technologies. In response to customers’ needs, Hovione is investing in new technologies, many of them capable of handling highly potent compounds. These will help drive compounds with development challenges from early clinical to market,” said Guy Villax, chief executive officer of Hovione.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics